NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Innovac Therapeutics

Innovac Therapeutics

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.innovactx.com/

Last Round

Early Funding

Sep 1, 2023

Total Funding Raised

$18M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Innovac Therapeutics is a biotechnology company that develops mRNA-based vaccines and therapeutics for oncology and infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

mRNA therapeuticslipid nanoparticleLNPmRNA vaccinedrug discoverybiotech platformmRNA designneoantigen designbiotech CDMOcomputational biologymRNA manufacturingvaccine developmentpreclinical researchimmunology assaybiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Innovac Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Innovac Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Innovac Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingSep 1, 2023

Key People

Founding team and executive leadership

Chi Zhang

Chief Executive Officer, Co-Founder

Founding Team

Innovac Therapeutics Investors

Notable investors and investment history

Innovac Therapeutics investors
InvestorRounds
Yuanjing CapitalEarly Funding
Yunion Health InvestmentsEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Monthly visitors grew 64% MoM, from 1.2K to 2K.

Innovac Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Innovac Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Innovac Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range14
Year Founded2022
Last FundingSep 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.